CBO’s Estimates of the Effects of Changes in the Manufacturers’ Discount in the Part D Coverage Gap


In a letter to Congressman Mark Meadows, CBO explains its estimate for section 53116 of the Bipartisan Budget Act requiring brand-name prescription drug manufacturers to increase the discount offered to some Medicare Part D beneficiaries.

View Document
55.67 KB